Case Study 1. Cervical Cancer Screening and Sexually Transmitted Infections Case Studies
|
|
- Elwin Craig
- 5 years ago
- Views:
Transcription
1 Case Study 1 Cervical Cancer Screening and Sexually Transmitted Infections Case Studies Joyce, a 32 year old returning veteran, comes in for a Well Woman visit. She has a history of an abnormal Pap before her deployment which was two years ago. Vital signs: 5 feet 6 inches tall, 141 lbs., HR 75, RR 17, temp 97.9 F, BP 122/82, non smoker. 2 Q1: Joyce s Pap smear results come back as ASC- US (atypical squamous cells of undetermined significance). What would you do next? A. If liquid based cytology was used, await reflex HPV testing results. If positive, refer to colposcopy. B. Refer immediately to colposcopy. C. Repeat Pap test in 6 months. Q1: Joyce s Pap smear results come back as ASC- US (atypical squamous cells of undetermined significance). What would you do next? A. If liquid based cytology was used, await reflex HPV testing results. If positive, refer to colposcopy. B. Refer immediately to colposcopy C. Repeat Pap test in 6 months 3 4 Discussion Points Discussion Points Option A: Reflex testing for HPV (if liquid cytology is used, or if a separate sample is collected at time of Pap) is preferred for patient convenience and cost effectiveness Women who test HPV negative: risk of harboring CIN 2/3+ is less than 2%; can perform co testing in 3 years Women who test HPV positive: refer for colposcopy due to 15 27% chance of CIN 2/3+ (unless under the age of 25 where repeat testing in 1 year is suggested) Option B: Proceeding immediately to colposcopy is no longer recommended Option C: If reflex HPV testing is not available, a follow up Pap in 1 year is an option. If one year FU is ASCUS or worse, colposcopy is recommended. The rate of loss to follow up is substantial: 1. Loss of 15 25% in research settings 2. Loss of 54 81% in clinical practice settings 5 6 1
2 Q2: Joyce asks about her chance of having cervical cancer. Based on her ASCUS and HPV neg test results, how will you respond? Q2: Joyce asks about her chance of having cervical cancer. Based on her ASCUS and HPV neg test results, how will you respond? A. <1% B. 1 5% C. 6 10% D. >10% A. <1% B. 1 5% C. 6 10% D. >10% 7 8 Discussion The risk of cancer is very low ( %), and the risk of CIN 2/3+ for any individual patient is also low (2%) Q3: What if Joyce s Pap smear results come back as L-SIL (low-grade squamous intraepithelial lesion)? Co-testing was not performed. What is your next step? Use the table on the next slide to guide your decision. B. Repeat Pap smear in 6 months C. Refer for colposcopy 9 10 Pap result CIN1 CIN2/3 Cancer Normal Pap up to 10% <1% 0.25% ASC US, HPV neg <10% <1.5% <0.01% Normal Pap, HPV+ <1.1% <0.08% ASC US, HPV % 7 18% <0.1% LGSIL 50 60% 2 19% 0.16% HGSIL 20% up to 70% 7% Q3: What if Joyce s Pap smear results come back as L-SIL (low-grade squamous intraepithelial lesion)? Co-testing was not performed. What is your next step? B. Repeat Pap smear in 6 months C. Refer for colposcopy Management options for L SIL result, no co testing: B. Repeat Pap smear in 6 months C. Refer for colposcopy
3 Discussion An L SIL diagnosis is associated with a positive test result for highrisk HPV in most women (83% of the women with L SIL cytology according to the ALTS study*). Therefore, reflex HPV testing is of limited value for triaging colposcopy. There is a high incidence of CIN 2 and 3 in patients with L SIL (15% and 30% respectively). However, for women under the age of 25 with L SIL, regardless of HPV status, immediate colposcopy is not recommended. Q.4: What if Joyce s Pap smear results come back as H-SIL (high-grade squamous intraepithelial lesion)? What is your next step? Use the table on the next slide to guide your decision. B. Repeat Pap smear in 6 12 months C. Refer to Gynecology for colposcopy and/or other procedures *The ASCUS/LSIL Study (ALTS) Group. J Natl Cancer Inst, 2000: 92: Pap result CIN1 CIN2/3 Cancer Normal Pap up to 10% <1% 0.25% ASC US, HPV neg <10% <1.5% <0.01% Normal Pap, HPV+ <1.1% <0.08% ASC US, HPV % 7 18% <0.1% LGSIL 50 60% 2 19% 0.16% HGSIL 20% up to 70% 7% Q.4: What if Joyce s Pap smear results come back as H-SIL (high-grade squamous intraepithelial lesion)? What is your next step? B. Repeat Pap smear in 6 12 months C. Refer to Gynecology for colposcopy and/or other procedures Management options for H SIL result: B. Repeat Pap smear in 6 12 months C. Refer to Gynecology for colposcopy and/or other procedures Discussion Among women with H SIL cytology results, greater than 70% have been reported to have CIN2 or CIN3, and 1 5% harbor invasive cancer. Therefore, a referral to a gynecologist for colposcopy is essential. Joyce, continued Q5. Six months later, Joyce presents with complaints of itching and vaginal discharge. What are possible diagnoses? F. All of the above
4 Q5. Six months later, Joyce presents with complaints of itching and vaginal discharge. What are the possible diagnoses? Q6. What components in the history and physical exam might help you distinguish between these diagnostic possibilities? F. All of the above Q6. What components in the history and physical exam might help you distinguish between these diagnostic possibilities? Sexual history to distinguish between infections that are sexually transmitted and other reproductive tract infections Query any recent antibiotic use, diabetes, or immunosuppression (make candida more likely) Inspect the vulva, looking for areas of erythema, edema, ulceration or chronic vulvar skin changes. Palpate with a cottontipped applicator to elicit areas of tenderness. Inspect the vagina and cervix Assess the color, consistency, and odor of discharge Q7. What are the next diagnostic steps? A. Vaginal ph B. Amine (whiff test) C. Potassium hydroxide (KOH) smear D. Normal saline microscopy E. BD Affirm TM point of care testing F. All of the above Q7. What are the next diagnostic steps? A. Vaginal ph B. Amine (whiff test) C. Potassium hydroxide (KOH) smear D. Normal saline microscopy E. BD Affirm TM testing F. All of the above Discussion Obtain specimens from lateral vaginal wall for laboratory evaluation. Evaluations should include vaginal ph, amine (whiff) test, saline and 10% potassium hydroxide (KOH) smears for microscopic examination. Normal ph (< 4.5) rules out bacterial vaginosis, whereas ph > 4.5 has a limited differential diagnosis. Perform whiff test for amines by placing a drop of 10% KOH on vaginal secretions and checking for fishy odor. Saline microscopy permits identification of trichomonads and clue cells. BD Affirm TM can identify candida species, trichomonas vaginalis, and gardnerella vaginalis. Turnaround time may vary by facility
5 Q8. Your exam reveals a positive whiff test and a ph >5. What is the most likely diagnosis? Q8. Your exam reveals a positive whiff test and a ph >5. What is the most likely diagnosis? Q9. What treatment is least effective? Q9. What treatment is least effective? A. Oral Metronidazole B. Topical Metronidazole C. Clindamycin D. Tinidazole E. Triple sulfa A. Oral Metronidazole B. Topical Metronidazole C. Clindamycin D. Tinidazole E. Triple sulfa Q10. Which of the following would you NOT do if Joyce s symptoms don t improve? A. Re evaluate for cure B. Re evaluate for another cause of vaginitis C. Recommend douching D. Query about unprotected sex Q10. Which of the following would you NOT do if Joyce s symptoms don t improve? A. Re evaluate for cure B. Re evaluate for another cause of vaginitis C. Recommend douching D. Query about unprotected sex
6 Q11. Your exam reveals vulvar edema, erythema, and a cheesy white discharge. What is the most likely diagnosis? Q11. Your exam reveals vulvar edema, erythema, and a cheesy white discharge. What is the most likely diagnosis? Q12. Which treatment would you NOT consider? Q12. Which treatment would you NOT consider? A. Topical imidiazole B. Topical metronidazole C. Oral fluconazole A. Topical imidiazole B. Topical metronidazole C. Oral fluconazole Discussion Point Oral fluconazole is good if Joyce has already tried topical imidiazole Also, topical treatment is messy and the oral fluconazole is a one dose pill Q13. Which of the following would you do if Joyce s symptoms don t improve? A. Obtain a culture to confirm type of candida B. Assess for risk factors that potentially promote candida C. Treat the infection for longer period of time
7 Q13. Which of the following would you do if Joyce s symptoms don t improve? A. Obtain a culture to confirm type of candida B. Assess for risk factors that potentially promote candida C. Treat the infection for longer period of time All options are feasible. Discussion Points Option A: May be dealing with another type of candida (candida tropicalis or candida glabrata) which doesn t respond well to fluconazole. Obtain a culture to confirm type of candida. Option B: Many women have risk factors that could promote candida. Assess for antibiotic use (e.g., acne treatment), change to a different/low dose OCP, assess for diabetes mellitus and confirm that she is well controlled. Options C and D: May need to treat infection for a longer period of time (repeat doses of fluconazole on day 4/7). Consider treating Joyce s partner Q14. Your exam reveals a frothy, yellow-green discharge with erythematous punctuate lesions on the cervix. Whiff test is negative and ph is normal. What is the most likely diagnosis? Q14. Your exam reveals a frothy, yellow-green discharge with erythematous punctuate lesions on the cervix. Whiff test is negative and ph is normal. What is the most likely diagnosis? D. Physiologic discharge E. Atrophic vaginitis D. Physiologic discharge E. Atrophic vaginitis Q15. What treatment would you provide? Q15. What treatment would you provide? A. Metronidazole 2gm oral dose x 1 B. Tinidazole C. Topical Metronidazole D. Oral fluconazole A. Metronidazole 2gm oral dose x1 B. Tinidazole C. Topical Metronidazole D. Oral fluconazole Joyce s partner should also be treated as trichomonas is a sexually transmitted infection
8 Q16. What would you do if Joyce s symptoms don t improve? Q16. What would you do if Joyce s symptoms don t improve? Query about unprotected sex, other partners, and adherence to medication by Joyce and her partner. Reassess for other cause of vaginitis after treatment (i.e., candida after exposure to ABX) Q17. Before Joyce leaves your office, what advice might you give her based on the diagnosis of a new STI? Q17. Before Joyce leaves your office, what advice might you give her based on the diagnosis of a new STI? There are three major concerns 1. Discuss her sexual practices: Address the issue of multiple sexual partners in a sensitive fashion. Ensure you understand the following: Are all of her sexual encounters consensual? This addresses the possibility of rape or sexual abuse. What are Joyce s motives for having multiple sexual partners? This can reveal possible psychological problems, low selfesteem, substance use, etc. 2. Discuss her high risk of further STI exposure from unprotected sex 3. Discuss contraception
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely
More informationX-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers
X-Treme Primary Care: HPV and STIs Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers Learning Objectives Review recommendations for HPV related cancer screening in
More information**Florida licensees, please note: This exercise is NOT intended to fulfill your state education requirement for molecular pathology.
EDUCATIONAL COMMENTARY VAGINAL INFECTIONS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn
More informationVaginitis. Vaginitis: Differential Diagnosis. Differential Diagnosis (con t) Useful historical items. Infectious vaginitis 60 %
Presenter Disclosure Information 4:45 5:30 pm Case Studies in Vaginitis SPEAKER Martin Quan, MD The following relationships exist related to this presentation: Martin A. Quan, MD: No financial relationships
More informationVaginitis. Differential Diagnosis (con t) Vaginitis: Differential Diagnosis
3:15 4:00 PM Case Studies in Vaginitis SPEAKER Martin A. Quan, MD Vaginitis one of the most common gynecologic disorders 10 million office visits/ year and 7 % visits to gynecologists 1 % antibiotics prescribed
More informationClinical Practice Guidelines June 2013
Clinical Practice Guidelines June 2013 General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method for the early
More informationCervical Cancer Screening and Sexually Transmitted Infections
Cervical Cancer Screening and Sexually Transmitted Infections Primary author: Catherine Staropoli, MD VA Maryland Healthcare System Contributors: Kathleen McIntyre Seltman, MD VA Pittsburgh Healthcare
More informationAppropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
More informationVaginitis. Antibiotics Changes in hormone levels due to pregnancy, breastfeeding, or menopause Douching Spermicides Sexual intercourse Infection
WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 Vaginitis Vaginitis is an inflammation of a woman s vagina. It is one of the most common reasons why women see their health care providers.
More informationBurdensome Vaginal Infections: Best Diagnostic Practices for Driving Better Patient Outcomes
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationTRICHOMONAS VAGINALIS
TRICHOMONAS VAGINALIS What s New: There are no changes to this guideline. Introduction Trichomonas vaginalis (TV) is a flagellated protozoan that is a parasite of the genital tract. Due to site specificity,
More informationComplex Vaginitis Cases: Applying New Diagnostic Methods to Enhance Patient Outcomes ReachMD Page 1 of 5
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationVaginitis Do I have to look?
Vaginitis Do I have to look? { Josette D Amato, D.O. Assistant Professor Department of Obstetrics & Gynecology Wright State University Boonshoft School of Medicine Pre-test Amsel s Diagnostic Criteria
More informationICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way
ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING Central Valley Public Health: Women's Way ICD-9-CM (Top 35) ICD-10-CM ICD-10-CM Description COMMENTS V10.3: Personal history of malignant neoplasm of Z85.3
More informationDr Lilianne Scholtz (MBBCh)
Dr Lilianne Scholtz (MBBCh) I have a discharge. It s itchy and it burns. My urine burns too. Diagnosis based on symptoms alone is accurate in ~34 % of women because symptoms are very non-specific Sobel
More informationHer Diagnosis Matters: What Can You Do to Prevent Misdiagnosis of Vaginitis?
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-industry-feature/her-diagnosis-matters-what-can-you-do-toprevent-misdiagnosis-of-vaginitis/9603/
More informationPRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT
PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT QUESTION #1 WHICH OF THE FOLLOWING IS NOT A RISK FACTOR FOR CERVICAL CANCER? A. HIGH RISK HPV B. CIGARETTE SMOKING C.
More informationMicroscopy Competency/Training For Clinic-Based Providers
Microscopy Competency/Training For Clinic-Based Providers OSBHCN October 11, 2013 Diane Avenoso, MPH, MT(ASCP)SBB, CQA(ASQ) Clinical Laboratory Inspector/Compliance Specialist OHA, Oregon State Public
More informationHPV & CERVICAL CANCER POLICY & LEGISLATIVE TOOLKIT, 3 RD EDITION
HPV Vaccine FAST FACTS: Payer & Reimbursement Strategies Medicaid: Many state Medicaid programs cover the HPV vaccine, though this coverage varies by state. Information on coverage can be found through
More informationWhat is a Pap smear?
Pap smear What is a Pap smear? A Pap smear is a test that checks for changes in the cells of your cervix. The cervix is the lower part of the uterus that opens into the vagina. Developed over forty years
More informationVaginitis. Is vaginal discharge ever normal? Women with vaginal discharge. Vaginal symptoms are very common. Patient with chronic vaginal discharge
Vaginitis Is the wet prep out of the building? No disclosures related to this topic Images are cited with permissions Barbara S. Apgar, MD, MS Professor of Family Medicine University of Michigan Health
More informationPREVENTION OF CERVICAL CANCER
PREVENTION OF CERVICAL CANCER Author: Dr R. Fuentes MBchb, Havana Spec. OB,GY-Havana- 2011 CONTENT TABLE Abbreviations 2 Introduction 4 The natural history of Cervical cancer 4 Risk Factors 4 Incidence
More informationCorporate Medical Policy
Corporate Medical Policy Multitarget Polymerase Chain Reaction Testing for Diagnosis of File Name: Origination: Last CAP Review: Next CAP Review: Last Review: multitarget_polymerase_chain_reaction_testing_for_diagnosis_of_bacterial_vaginosis
More informationCervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH
Cervical Testing and Results Management An Evidenced-Based Approach April 22nd, 2010 Debora Bear, MSN, MPH Assistant Medical Director for Planned Parenthood of New Mexico, Inc. Burden of cervical cancer
More informationVaginitis. Syllabi/Slides for this program are a supplement to the live CME session and are not intended for other purposes.
2:45 3:30pm Case Studies in Vaginitis SPEAKER Martin A. Quan, MD Presenter Disclosure Information The following relationships exist related to this presentation: Martin A. Quan, MD has no financial relationships
More informationEradicating Mortality from Cervical Cancer
Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus
More informationThe Pap Smear Test. The Lebanese Society of Obstetrics and Gynecology. Women s health promotion series
The Lebanese Society of Obstetrics and Gynecology Women s health promotion series The Pap Smear Test Since the Pap smear test started to be used the number of cases of cervical cancer was greatly reduced.
More informationHPV Knowledge Survey Healthcare Providers
1. What is your age? m 20-24 m 25-35 m 36-45 m 46-55 m 56-65 m 66-75 2. What is your gender? m Male m Female m Other 3. Which ethnic group do you identify with (please tick all that apply)? m New Zealand
More informationFaculty Pap Smear Guidelines: Family Planning Update 2008 Part Two
Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health
More informationWhat is HPV and why is it so important?
Understanding HPV For many years, Pap smears have been the most effective way to tell if a woman is at risk of developing cervical cancer. The Pap smear may also identify a common viral infection called
More informationVAGINITIS What Makes a Good Vagina Go Bad?
VAGINITIS What Makes a Good Vagina Go Bad? The 23 rd Annual Charleston Advanced Practice Registered Nurses Conference Judith T. Burgis, M.D. Professor and Chair Palmetto Health/USC Medical Group February
More informationCase Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure
Disclosure Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics This
More informationManagement that provides continuity of care for women
Management that provides continuity of care for women If women are diagnosed with reproductive tract infection, prompt treatment should be instituted according to the WHO guidelines. Though it may be preferred
More informationCervical Screening for Dysplasia and Cancer in Patients with HIV
Cervical Screening for Dysplasia and Cancer in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute w w w.hivg uidelines.org Purpose of the Guideline Increase
More informationWhat is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Harris Health System
What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Manager @ Harris Health System What is a Pap Smear and when is it recommended? Pap smear The Pap smear is a screening
More informationClinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary
Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Glossary of Terms Colposcopy is the examination of the cervix, vagina and, in
More informationANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION
Electronic Journal of Pharmacology and Therapy Vol 4, 15-20 (2011) ISSN: 0973-9890 (Available online at wwwtcrjournalscom) Clinical Article ndexed in: ProQuest database Abstract, USA (ProQuest Science
More informationI have no financial interests to disclose.
Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests
More informationObjectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies
Cervical Cancer Screening Guidelines: Updates and Controversies I have no financial interests in any product I will discuss today. Jody Steinauer, MD, MAS University of California, San Francisco Objectives
More informationScreening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA
Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA Cancer Care Ontario Cervical Cancer Screening Goals Increase patient participation in cervical screening Increase primary care
More informationHPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series
HPV and Cervical Cancer, Screening and Prevention John Ragsdale, MD July 12, 2018 CME Lecture Series We have come a long Way Prevalence HPV in Young Adults in U.S HPV genotypes 55-60% of All cancers 20%
More informationClinical Policy: Diagnosis of Vaginitis Reference Number: CP.MP.97
Clinical Policy: Reference Number: CP.MP.97 Effective Date: 06/16 Last Review Date: 06/16 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
More informationInvestigation and Management of Vaginal Discharge in Adult Women
Investigation and Management of Vaginal Discharge in Adult Women SUMMARY POINTS A detailed history, including sexual history, should be taken to explore potential causes and guide investigation and management.
More informationSamuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida
Making sense of the new Pap smear screening guidelines. Samuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida Case 17 year old G1P0010 with first sexual encounter
More informationEuropean Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs
European Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs Introduction to the Survey The purpose of this project is to collect information regarding
More informationStudy to Evaluate Targeted Management and Syndromic Management in Women Presenting with Abnormal Vaginal Discharge
DOI 10.1007/s13224-016-0879-x ORIGINAL ARTICLE Study to Evaluate Targeted Management and Syndromic Management in Women Presenting with Abnormal Vaginal Discharge Veena Meena 1 Charu Lata Bansal 2 Received:
More informationMaking Sense of Cervical Cancer Screening
Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because
More informationSESSION J4. What's Next? Managing Abnormal PAPs in 2014
37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, 2014 2:45 SESSION J4 What's Next? Managing Abnormal PAPs in 2014 Session Description: Linda Eckert, MD Review current guidelines
More informationClinically Microscopically Pathogenesis: autoimmune not lifetime
Vulvar Diseases: Can be divided to non-neoplastic and neoplastic diseases. The neoplastic diseases are much less common. Of those, squamous cell carcinoma is the most common. most common in postmenopausal
More informationCERVICAL CANCER FACTSHEET. What is cervical cancer?
CERVICAL CANCER FACTSHEET What is cervical cancer? ENGAGe is releasing a series of factsheets to raise awareness of gynaecological cancers and to support its network to work at a grassroots level. Take-up
More informationProposed new national cervical screening program. Dr Elizabeth Jackson Obstetrician Gynaecologist Cairns
Proposed new national cervical screening program Dr Elizabeth Jackson Obstetrician Gynaecologist Cairns www.drelizabethjackson.com Cervical cancer in Australia 12th most common cancer affecting Australian
More informationWhat is cervical cancer?
What is cervical cancer? The cervix is the bottom part, or neck, of the uterus. Cervical cancer happens when normal cells in the cervix change into abnormal cells, and grow out of control. Most women whose
More informationBCCCP Approved ICD-9 Code List Fiscal Year 2010
BCCCP Approved ICD-9 List Fiscal Year 2010 Diagnosis Description 174.0 Malignant neoplasm of female breast; Nipple and areola 174.1 Malignant neoplasm of female breast; Central portion 174.2 Malignant
More informationYour Colposcopy Visit
Introduction Welcome to the colposcopy clinic. This booklet tells you about. The colposcopy examination.. Tests that are done in the colposcopy clinic.. What these tests look for Take a few minutes to
More informationManagement Algorithms for Abnormal Cervical Cytology and Colposcopy
Management Algorithms for Abnormal Cervical Cytology and Colposcopy Table of Contents Standard Colposcopic Definitions... 1 Guidelines for the Assessment of Abnormal Cervical Cytology... 2 Ia: Persistent
More informationEDUCATIONAL COMMENTARY - CLUE CELL MORPHOLOGY: DIAGNOSTIC CONSIDERATIONS
EDUCATIONAL COMMENTARY - CLUE CELL MORPHOLOGY: DIAGNOSTIC CONSIDERATIONS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE
More informationPerfecting the Prevention of Cervical cancer. I have no financial interests in any product I will discuss today. Preview
Perfecting the Prevention of Cervical cancer Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests in any
More information10/20/2015. Valerie Ballard, DNP Women s Health Nurse Practitioner
S.Storm - Dementia Valerie Ballard, DNP Women s Health Nurse Practitioner A WELL VISIT IS PART OF A JOURNEY TO WELLNESS AND HEALTH FOR OUR PATIENTS. As a provider, take the opportunity to listen, teach
More informationWOMEN'S INTERAGENCY HIV STUDY GYNECOLOGICAL EXAM FORM 8
WOMEN'S INTERAGENCY HIV STUDY GYNECOLOGICAL EXAM FORM 8 AFFIX ID LABEL HERE ---> PARTICIPANT ID: (Enter number here only if ID label is not available) - - - WIHS STUDY VISIT #: FORM VERSION: 04/01/99 EXAMINER'S
More informationInternational Journal of Biological & Medical Research
Int J Biol Med Res. ; 2(3): 757-761 Int J Biol Med Res www.biomedscidirect.com Volume 2, Issue 3, July BioMedSciDirect Publications Contents lists available at BioMedSciDirect Publications International
More informationType Description Date Version Performed By Notes. Date Revised: September 2009; Revised by: Marguerite Roemer, MT (ASCP) SM and Clayton Hooper, RN
Zuckerberg San Francisco General Hospital and Trauma Center Clinical Laboratory 1001 Potrero Avenue, San Francisco, CA 94110 Barbara Haller, MD, PhD, Director 48667.258 Saline and KOH Vaginal Wet Mounts
More informationPap Test. F r e q u e n t l y A s k e d Q u e s t i o n s
Pap Test Q: What is a Pap test? A: The Pap test, also called a Pap smear, checks for changes in the cells of your cervix. The cervix is the lower part of the uterus (womb) that opens into the vagina (birth
More informationPap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed???
Pap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed??? Arlene Evans-DeBeverly, PA-C Copyright 2012 There are always ongoing changes in gynecology, including the
More informationRemind me, what s an STI? And why are they relevant to me?
Remind me, what s an STI? And why are they relevant to me? Sexually transmitted infections (STIs) are often caused by bacteria or viruses and are typically (though not always) passed from one person to
More informationVAGINITIS: IT S NOT JUST YEAST. Index of this slide set VULVOVAGINITIS DAVID J. BOES, D.O., FACOOG MSU-COM SCS BOOT CAMP, 2018
VAGINITIS: IT S NOT JUST YEAST DAVID J. BOES, D.O., FACOOG MSU-COM SCS BOOT CAMP, 2018 Index of this slide set Slide # 1-14: General aspects of Vaginitis Slide # 15-35: Trichomoniasis Slide # 36-59 Bacterial
More informationHuman Papillomavirus (HPV) and Cervical Cancer Prevention
Human Papillomavirus (HPV) and Cervical Cancer Prevention MOA Autumn Convention November 3, 2017 David J Boes, DO, FACOOG (Dist.) Associate Professor, MSU-COM 1 Disclosures None relative to this presentation
More informationCervical Dysplasia and HPV
Cervical Dysplasia and HPV J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse HPV Double stranded DNA virus The HPV infect epithelial cells of the skin and mucous membranes Highest risk
More informationTwenty-first refresher course. Chan Kit Sheung
Twenty-first refresher course Chan Kit Sheung 7-5-2015 Case 1 Case 1, 29y old, G3P2, referred from MCHC Cervical smear on 27-9-2013: LGSIL, defaulted appointment Cervical smear in 12/2014: negative Colposcopy
More informationCervical Cancer Screening. David Quinlan December 2013
Cervical Cancer Screening David Quinlan December 2013 Cervix Cervical Cancer Screening Modest variation provincially WHO and UK begin at 25 stop at 60 Finland begin at 30 stop at 60 Rationale for
More informationNews. Laboratory NEW GUIDELINES DEMONSTRATE GREATER ROLE FOR HPV TESTING IN CERVICAL CANCER SCREENING TIMOTHY UPHOFF, PHD, DABMG, MLS (ASCP) CM
Laboratory News Inside This Issue NEW GUIDELINES DEMONSTRATE GREATER ROLE FOR HPV TESTING IN CERVICAL CANCER SCREENING...1 NEW HPV TEST METHODOLOGY PROVIDES BETTER SPECIFICITY FOR CERVICAL CANCER...4 BEYOND
More informationCASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6. Friday, MARCH 18, 2016 STUDENT COPY
MHD II, Session 6, STUDENT Copy Page 1 CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6 Friday, MARCH 18, 2016 STUDENT COPY Resource for cases: ACP Medicine (Scientific American Medicine) - Vaginitis
More informationAckers, JP (2003) Trichomonas. In: The Oxford Textbook of Medicine. Oxford University Press, Oxford, 1:783-4.
Ackers, JP (2003) Trichomonas. In: The Oxford Textbook of Medicine. Oxford University Press, Oxford, 1:783-4. Downloaded from: http://researchonline.lshtm.ac.uk/15085/ DOI: Usage Guidelines Please refer
More informationVaginitis. Background. Vaginal Environment. Vaginitis. This is a PDF version of the following document:
National STD Curriculum PDF created November 12, 2018, 6:30 pm Vaginitis This is a PDF version of the following document: Disease Type 2: Syndrome-Based Diseases Disease 7: Vaginitis You can always find
More informationClinical Policy: Diagnosis of Vaginitis Reference Number: CP.MP.97
Clinical Policy: Reference Number: CP.MP.97 Effective Date: 06/16 Last Review Date: 06/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
More informationPreventing Cervical Cancer 2018 WHAT THIS WILL MEAN FOR PRIMARY CARE
Preventing Cervical Cancer 2018 WHAT THIS WILL MEAN FOR PRIMARY CARE DR GARY FENTIMAN, CLINICAL LEADER COLPOSCOPY, N C S P TAKE-HOME LESSONS Vaccination is Primary Prevention for Cervical Cancer Women
More informationSTI Diagnostics Redesign. HVS and Chlamydia Resource Pack
Important! 1. This information is intended to support practitioners in the management of common sexual health problems and it is therefore essential that each doctor and nurse receives a copy. 2. Future
More informationThe Gynecological Exam. Pelvic Exams and Cervical Cancer Screening. Learning Objectives. Focused History
The Gynecological Exam Components of the exam vary by age and lifestyle: Pelvic Exams and Cervical Cancer Screening 1. Focused history 2. Physical exam Pelvic exam 3. Screening Pap smear for cervical cancer
More informationName of Policy: Speculoscopy
Name of Policy: Speculoscopy Policy #: 095 Latest Review Date: September 2011 Category: Medicine/OB Gyn Policy Grade: C Background/Definitions: As a general rule, benefits are payable under Blue Cross
More informationSexually Transmitted Infections. Kim Dawson October 2010
Sexually Transmitted Infections Kim Dawson October 2010 Objectives: You will learn about: Sexually Transmitted Infections (STI s). How they are transferred. High risk behavior. The most common STI s. How
More informationOverview of Wet Preps and Gram stains. Lorna Rabe Central Lab Magee-Womens Research Institute Pittsburgh, Pa
Overview of Wet Preps and Gram stains Lorna Rabe Central Lab Magee-Womens Research Institute Pittsburgh, Pa Vaginal Flora A secondary objective of the 035 study is to assess the effectiveness of BufferGel
More informationOriginal Policy Date
MP 2.04.03 Cervicography Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to Medical Policy Index Disclaimer
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics
More informationJanuary 15, 2009 (202) PROPOSALS TO IMPROVE CYTOLOGY PROFICIENCY TESTING REQUIRED BY THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Office of Media Affairs CMS FACT SHEET FOR IMMEDIATE RELEASE Contact:
More informationShould Anal Pap Smears Be a Standard of Care in HIV Management?
Should Anal Pap Smears Be a Standard of Care in HIV Management? Gordon Dickinson, M.D., FACP Professor of Medicine and Chief Infectious Diseases, Miller School of Medicine Short Answer: NO But 15-20 HPV
More informationDisclosures. Learning objectives. George F. Sawaya, MD. I have nothing to disclose.
Well Woman Visits in 2018: How Should We Approach Cervical Cancer Screening and Routine Pelvic Examinations? George F. Sawaya, MD Disclosures I have nothing to disclose. Professor, Obstetrics, Gynecology
More informationDepartment of Health Standard for the Cervical Cancer Screening Program. Approval Date: 08 May 2018 Effective Date: 13 May 2018
Document Title: Department of Health Standard for the Cervical Cancer Screening Program Document Ref. Number: DOH/CCSC/SD/1.0 Version: 1.0 Approval Date: 08 May 2018 Effective Date: 13 May 2018 Last Reviewed:
More informationBursting Pelvic Inflammatory Disease.
www.infertiltysolutionsng.info/blog Disclaimer The information in this book is provided for educational purposes only and is not intended to treat, diagnose or prevent any disease. The information in this
More informationBacterial vaginosis (BV) results from the breakdown of
Comparative efficacy of oral lactobacillus rhamnosus (protexin) against metronidazole (flagyl) in the treatment of bacterial vaginosis: A ramdomized clinical trial* By Marianne Rose L. Go, MD and Rosendo
More informationWHAT PATIENTS BRING TO THE MEDICAL ENCOUNTER DEALING WITH THE WHOLE PATIENT FACULTY PACKET
WHAT PATIENTS BRING TO THE MEDICAL ENCOUNTER DEALING WITH THE WHOLE PATIENT FACULTY PACKET Faculty Introduction to the Case The overall objective of this case is to provide students with an opportunity
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Prevention: 2012 and Beyond George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics University of California,
More informationSetting The setting was primary care. The economic study was carried out in the USA.
"Shotgun" versus sequential testing: cost-effectiveness of diagnostic strategies for vaginitis Carr P L, Rothberg M B, Friedman R H, Felsenstein D, Pliskin J S Record Status This is a critical abstract
More informationPreventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64
Preventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64 1. BMI - Documented in patients medical record on an annual basis. Screen for obesity and offer intensive counseling and behavioral
More informationUnderstanding Your Pap Test Results
Understanding Your Pap Test Results Most laboratories in the United States use a standard set of terms called the Bethesda System to report pap test results. Normal: Pap samples that have no cell abnormalities
More informationBecoming a colposcopist: Colposcope case studies
Becoming a colposcopist: Colposcope case studies Seon-Kyung Lee, M.D. Department of Obstetrics and Gynecology College of Medicine, Kyung Hee University Value of Colposcopy Cytology is an effective screening
More informationBacterial Vaginosis & VVC: How Can We Improve Current Diagnosis Methods?
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/womens-health-update/bacterial-vaginosis-vvc-how-can-we-improvecurrent-diagnosis-methods/10413/
More informationObjectives. Background. Background. Background. Background 9/26/16. Update on Cervical and HPV Screening Guidelines: To pap or not to pap?
Update on Cervical and HPV Screening Guidelines: To pap or not to pap? Marina Delazari Miller MD Clinical Assistant Professor Department of Obstetrics & Gynecology University of Iowa Hospitals and Clinics
More informationCervical Cancer Screening Guidelines Update
Frontier AIDS Education and Training Center Cervical Cancer Screening Guidelines Update Hillary Liss, MD Harborview Medical Center, Madison and Adult Medicine Clinics Frontier AETC, Medical Program Director
More information!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$
!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
More information